• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - MAPLE GROVE ELUVIA¿ DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - MAPLE GROVE ELUVIA¿ DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number H74939295601510
Device Problems Bent (1059); Fracture (1260); Difficult to Remove (1528); Activation, Positioning or Separation Problem (2906)
Patient Problems Perforation of Vessels (2135); Device Embedded In Tissue or Plaque (3165)
Event Date 10/12/2016
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.(b)(4).
 
Event Description
It was reported that a vessel perforation, stent deployment issue and a stent fracture occurred.Vascular access was obtained using a contralateral approach.The highly calcified and moderately tortuous target lesion was located in the chronic total occluded superficial femoral artery.Following pre-dilation, a 6x150, 130cm eluvia¿ drug-eluting vascular stent system was advanced to the target lesion over a 0.035 guidewire.After approximately 1/3 of the stent was deployed, the stent deployment thumbwheel and pull grip did not work.The stent was attempted to be retrieved by pulling back with extreme difficulty.However, this led to the stent elongating and ultimately 3-4cm of the stent fracturing and remaining inside the patient.During the removal attempts, the patient experienced an arterial perforation.The perforation and fragmented stent piece were covered with three additional stents.No further complications were reported and the patient was discharged without significant complication.
 
Manufacturer Narrative
Device evaluated by mfr.: returned product consisted of an eluvia stent delivery system (sds).The handle was separated as received.The shaft and handle were examined.There was a buckle at the nose cone.There was a kink in the inner shaft at the distal end of the middle shaft.The stent was not returned.The sds was in the deployed state, the inner was pulled out 150mm.The tip had impressions of the stent.The first distal tooth on the rack was damaged.The middle sheath was pulled out of the retainer clip.There was no evidence of any product quality deficiencies.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The most probable root cause is operational context as device performance was limited due to anatomical procedural factors.(b)(4).
 
Event Description
It was reported that a vessel perforation, stent deployment issue and a stent fracture occurred.Vascular access was obtained using a contralateral approach.The highly calcified and moderately tortuous target lesion was located in the chronic total occluded superficial femoral artery.Following pre-dilation, a 6x150, 130cm eluvia¿ drug-eluting vascular stent system was advanced to the target lesion over a 0.035 guidewire.After approximately 1/3 of the stent was deployed, the stent deployment thumbwheel and pull grip did not work.The stent was attempted to be retrieved by pulling back with extreme difficulty.However, this led to the stent elongating and ultimately 3-4cm of the stent fracturing and remaining inside the patient.During the removal attempts, the patient experienced an arterial perforation.The perforation and fragmented stent piece were covered with three additional stents.No further complications were reported and the patient was discharged without significant complication.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA¿ DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - MAPLE GROVE
one scimed place
maple grove MN 55311
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key6091439
MDR Text Key59552444
Report Number2134265-2016-09921
Device Sequence Number1
Product Code NIU
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
SIMILAR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/13/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/09/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/30/2017
Device Model NumberH74939295601510
Device Catalogue Number39295-60151
Device Lot Number19396993
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/31/2016
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/29/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/12/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
SHEATH: COOK 45 CM 6F STRAIGHT; TERUMO 0.035 GUIDEWIRE
Patient Outcome(s) Required Intervention;
Patient Age67 YR
-
-